about
Assessment of the prophylactic speed of kill of Frontline Tri-Act® against ticks (Ixodes ricinus and Rhipicephalus sanguineus) on dogsEfficacy of afoxolaner in a clinical field study in dogs naturally infested with Sarcoptes scabieiImpact of climate change in the epidemiology of vector-borne diseases in domestic carnivoresPreventive efficacy of a topical combination of fipronil – (S)-methoprene – eprinomectin – praziquantel against ear mite (Otodectes cynotis) infestation of cats through a natural infestation modelPreventive efficacy of NexGard Spectra® against Dipylidium caninum infection in dogs using a natural flea (Ctenocephalides felis) infestation modelPrevention of transmission of Ehrlichia canis by Rhipicephalus sanguineus ticks to dogs treated with a combination of fipronil, amitraz and (S)-methoprene (CERTIFECT®).The ability of an oral formulation of afoxolaner to block the transmission of Babesia canis by Dermacentor reticulatus ticks to dogs.Efficacy of a topical application of Certifect® (fipronil 6.26% w/v, amitraz 7.48% w/v, (S)-methoprene 5.63% w/v) for the treatment of canine generalized demodicosisAfoxolaner against fleas: immediate efficacy and resultant mortality after short exposure on dogsEvaluation of the efficacy of monthly oral administration of afoxolaner plus milbemycin oxime (NexGard Spectra(®), Merial) in the prevention of adult Spirocerca lupi establishment in experimentally infected dogs.Immediate efficacy and persistent speed of kill of a novel oral formulation of afoxolaner (NexGardTM) against induced infestations with Ixodes ricinus ticks.Sustained speed of kill and repellency of a novel combination of fipronil and permethrin against Ctenocephalides canis flea infestations in dogs.Repellency, prevention of attachment and acaricidal efficacy of a new combination of fipronil and permethrin against the main vector of canine babesiosis in Europe, Dermacentor reticulatus ticks.Acaricidal efficacy of a new combination of fipronil and permethrin against Ixodes ricinus and Rhipicephalus sanguineus ticksRepellency and acaricidal efficacy of a new combination of fipronil and permethrin against Ixodes ricinus and Rhipicephalus sanguineus ticks on dogs.A novel combination of fipronil and permethrin (Frontline Tri-Act®/Frontect®) reduces risk of transmission of Babesia canis by Dermacentor reticulatus and of Ehrlichia canis by Rhipicephalus sanguineus ticks to dogs.Preventive efficacy of Frontline® Combo and Certifect® against Dipylidium caninum infestation of cats and dogs using a natural flea (Ctenocephalides felis) infestation model.Direct transmission of the cat flea (Ctenocephalides felis) between cats exhibiting social behaviourAmerican Association of Veterinary Parasitologists' review of veterinary fecal flotation methods and factors influencing their accuracy and use--is there really one best technique?Occurrence of Aelurostrongylus abstrusus and Troglostrongylus brevior in domestic cats in Greece.Efficacy of Broadline® spot-on against Aelurostrongylus abstrusus and Troglostrongylus brevior lungworms in naturally infected cats from Italy.Epidemiological survey of ticks and tick-borne pathogens in pet dogs in south-eastern ChinaKnock-down and speed of kill of a combination of fipronil and permethrin for the prevention of Ctenocephalides felis flea infestation in dogs.Assessment of the insecticidal activity of afoxolaner against Aedes aegypti in dogs treated with NexGard®.New method using quantitative PCR to follow the tick blood meal and to assess the anti-feeding effect of topical acaricide against Rhipicephalus sanguineus on dogs.Comparative efficacy of two oral treatments for dogs containing either afoxolaner or fluralaner against Rhipicephalus sanguineus sensu lato and Dermacentor reticulatus.Comparative speed of efficacy against Ctenocephalides felis of two oral treatments for dogs containing either afoxolaner or fluralaner.Reply to letter to the editor.Rhipicephalus sanguineus ticks: a new vector from the continent to the UK?Feline gastrointestinal parasitism in Greece: emergent zoonotic species and associated risk factors.Six-month field efficacy and safety of the combined treatment of dogs with Frontline Tri-Act® and NexGard Spectra®Correction to: Assessment of the efficacy of firocoxib (Previcox®) and grapiprant (Galliprant®) in an induced model of acute arthritis in dogsAssessment of the insecticidal activity of oral afoxolaner against Phlebotomus perniciosus in dogsPrevention of the transmission of Babesia rossi by Haemaphysalis elliptica in dogs treated with Nexgard®Assessment of the efficacy of firocoxib (Previcox®) and grapiprant (Galliprant®) in an induced model of acute arthritis in dogs
P50
Q22773169-E1BA15C4-7B05-4BCC-BA66-92C00C471AFDQ24823136-99334E5D-6820-41F5-9CB2-89EE0910FEB5Q26997247-59AF997B-FF10-481E-8608-453BA858355AQ29544618-04A17BBF-DA0C-4CCC-9519-7F9F155D646DQ30096756-DC63A920-101A-4219-9CE5-0CFAEBBD5842Q33405165-3F695B36-AEB4-4637-AA45-16D00D112CA1Q33835793-A17B62CC-F2E9-4663-88F2-B843B59E441DQ34038996-B3870CD3-7C2F-409E-BC81-01990BB3BDC9Q34434600-CFEA2B6B-37CB-4839-937F-8AD075FE34EAQ34537080-A130557E-6FCE-4086-A69F-56B664F389C7Q34669833-ACB5617D-910B-4D20-8606-EDA78CC332B8Q35046753-739B1078-47F9-4741-AA19-ABCB6E3C0A92Q35046789-CA6EA7E1-5D44-4507-B24C-F779FECA9532Q35047998-637F7519-DDBC-40F2-ADF0-A1C7DD4EF9AFQ36160183-C8D9D555-0DA5-4BCC-AB21-B30C9AD8BD98Q36301850-4074BB4B-F08F-4476-BB5B-326EFD886205Q37032960-2139472F-65C4-40C4-B35C-8579C19C4F81Q37366296-F5D882F4-4726-47C4-B88D-99589EF81976Q38217326-4A08AF4C-2D17-43AE-B9B3-2B31CFBFE731Q40312283-2377B0A0-DA69-4DC9-A299-E61662714CC3Q41373338-7C51A1BD-EED4-4199-A42A-E7D2805DB8E2Q41911568-1AF3B87E-A0C6-4808-BAE7-08EC7A0D9100Q42542495-3C64A4B8-6C11-4B5D-9CE7-8876DD38F332Q43047176-75B815A3-1C06-4166-8112-AF6CCD8308AFQ46483936-33A56B89-C264-47E7-90AD-9C5D07B5BF54Q46767517-6200825A-07FA-45AC-A23F-6BEFC9312FA9Q46964050-5CFEF421-205F-4985-9916-3476B5871C84Q52800803-2F68B6DD-AD29-4432-8175-131EFE4A09E2Q53530666-15E4FD78-F03D-41B6-BCB3-132DF1123687Q54241879-144ABBB2-30C9-42DF-AF31-04953922012AQ90249262-6DA3FEEA-2F79-4CF6-975D-FCB978983824Q90751667-6E1C4774-8EC5-4E3E-85F0-5338EDE2B496Q91117378-66A2AADD-209B-4EDB-8616-91325E5A905EQ92742278-E74A4179-761A-4A5D-84EF-9AA977E175DFQ92977423-1187DB60-A7D5-446A-8D4A-84F676D6CB1F
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Frederic Beugnet
@en
Frederic Beugnet
@nl
type
label
Frederic Beugnet
@en
Frederic Beugnet
@nl
prefLabel
Frederic Beugnet
@en
Frederic Beugnet
@nl
P31
P496
0000-0002-7040-7821